个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

ESG401, a novel Trop2 antibody-drug conjugate (ADC), and its efficacy evidence in HER2-negative metastatic breast cancer with brain metastases

| 导出 | |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Ma, F.[1] * ; Qiu, F.[2] ; Tong, Z.[3] ; Wang, J.[4] ; Shi, Y.[5] ; Li, L.[6] ; Yu, G.[7] ; Shi, H.[8] ; Wu, X.[9] ; Liu, A.[10] ; Zhang, Y.[11] ; Wang, H.[12] ; Cheng, Y.[13] ; Yang, H.[14] ; Li, H.[15] ; Chang, J.[16] ; Zhou, Q.[17] ;
机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Dept Med Oncol, Beijing, Peoples R China [2]Zhejiang Univ, Affiliated Hosp 2, Med Oncol Dept, Sch Med, Hangzhou, Zhejiang, Peoples R China [3]TMUCIH Tianjin Med Univ Canc Inst & Hosp, Breast Med, Tianjin, Peoples R China [4]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Med Oncol, Beijing, Peoples R China [5]TMUCIH Tianjin Med Univ Canc Inst & Hosp, Med Oncol Dept Breast Canc, Tianjin, Peoples R China [6]Zhejiang Univ, Affiliated Hosp 2, Sch Med, Med Oncol, Hangzhou, Peoples R China [7]Weifang Peoples Hosp, Med Oncol, Weifang, Peoples R China [8]Gannan Med Univ, Affiliated Hosp 1, Med Oncol, Ganzhou, Peoples R China [9]Hubei Canc Hosp, Mammary Ctr, Wuhan, Peoples R China [10]Nanchang Univ, Affiliated Hosp 2, Med Oncol, Nanchang, Jiangxi, Peoples R China [11]Beijing Hosp, Med Oncol, Beijing, Peoples R China [12]Nanchang Med Coll, Nanchang Peoples Hosp Affiliated, Breast Oncol Dept, Nanchang, Jiangxi, Peoples R China [13]Jilin Canc Hosp, Internal Med, Changchun, Jilin, Peoples R China [14]Hebei Univ, Affiliated Hosp, Med Oncol, Baoding, Peoples R China [15]Peking Univ Canc Hosp & Inst, Breast Med, Beijing, Peoples R China [16]Guizhou Med Univ, Affiliated Hosp, Breast Oncol Dept, Guiyang, Guizhou, Peoples R China [17]Shanghai Escugen Biotechnol Co Ltd, Clin Dev, Shanghai, Peoples R China
出处：
DOI： 10.1016/j.annonc.2024.08.292
ISSN：
基金：
Shanghai Escugen Biotechnology Co., Ltd.
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2025]版：
无
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2024]版：
无
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2023版]

第一作者：
第一作者机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Dept Med Oncol, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Ma F.,Qiu F.,Tong Z.,et al.ESG401, a novel Trop2 antibody-drug conjugate (ADC), and its efficacy evidence in HER2-negative metastatic breast cancer with brain metastases[J].ANNALS OF ONCOLOGY.2024,35:S359-S359.doi:10.1016/j.annonc.2024.08.292.
APA：
Ma, F.,Qiu, F.,Tong, Z.,Wang, J.,Shi, Y....&Zhou, Q..(2024).ESG401, a novel Trop2 antibody-drug conjugate (ADC), and its efficacy evidence in HER2-negative metastatic breast cancer with brain metastases.ANNALS OF ONCOLOGY,35,
MLA：
Ma, F.,et al."ESG401, a novel Trop2 antibody-drug conjugate (ADC), and its efficacy evidence in HER2-negative metastatic breast cancer with brain metastases".ANNALS OF ONCOLOGY 35.(2024):S359-S359

资源点击量：15101 今日访问量：3 总访问量：963 更新日期：2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持：重庆聚合科技有限公司 地址：保定市莲池区裕华东路212号